Clinical-Stage Pharmaceutical Company Completes IPO

Management had initiated a plan to file an S-1 for an IPO with the SEC, but the company lacked the technical accounting and financial reporting expertise needed to properly account for complex accounting issues and draft S-X compliant financial statements and the MD&A.

Services Provided
• IPO Readiness Assessment
• Technical Accounting
• Registration Statement
• SEC Comment Letter Response
• Sarbanes-Oxley Compliance
• Project Management

Results Delivered
We managed the IPO process within accelerated timelines and met filing deadlines. Our team served as the primary accounting/financial reporting function and effectively transitioned responsibilities to new management.

2018-07-12T12:10:14+00:00July 20th, 2017|Case Studies, Case Studies - Companies|